vs

Side-by-side financial comparison of BLACKBERRY Ltd (BB) and Esperion Therapeutics, Inc. (ESPR). Click either name above to swap in a different company.

Esperion Therapeutics, Inc. is the larger business by last-quarter revenue ($168.4M vs $141.8M, roughly 1.2× BLACKBERRY Ltd). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs -0.8%). Over the past eight quarters, BLACKBERRY Ltd's revenue compounded faster (17.8% CAGR vs 10.6%).

BlackBerry Limited, formerly Research In Motion (RIM), is a Canadian software company specializing in secure communications and the Internet of Things (IoT). Founded in 1984, it developed the BlackBerry brand of two-way pagers, smartphones, and tablets. The company later transitioned to providing software and services and holds critical software application patents.

Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.

BB vs ESPR — Head-to-Head

Bigger by revenue
ESPR
ESPR
1.2× larger
ESPR
$168.4M
$141.8M
BB
Growing faster (revenue YoY)
ESPR
ESPR
+144.6% gap
ESPR
143.7%
-0.8%
BB
Faster 2-yr revenue CAGR
BB
BB
Annualised
BB
17.8%
10.6%
ESPR

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
BB
BB
ESPR
ESPR
Revenue
$141.8M
$168.4M
Net Profit
$13.7M
Gross Margin
77.5%
Operating Margin
8.4%
50.6%
Net Margin
9.7%
Revenue YoY
-0.8%
143.7%
Net Profit YoY
224.5%
EPS (diluted)
$0.02
$0.32

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BB
BB
ESPR
ESPR
Q4 25
$141.8M
$168.4M
Q3 25
$129.6M
$87.3M
Q2 25
$121.7M
$82.4M
Q1 25
$141.7M
$65.0M
Q4 24
$143.6M
$69.1M
Q3 24
$126.2M
$51.6M
Q2 24
$123.4M
$73.8M
Q1 24
$102.1M
$137.7M
Net Profit
BB
BB
ESPR
ESPR
Q4 25
$13.7M
Q3 25
$13.3M
$-31.3M
Q2 25
$1.9M
$-12.7M
Q1 25
$-7.4M
$-40.5M
Q4 24
$-10.5M
Q3 24
$-19.7M
$-29.5M
Q2 24
$-41.4M
$-61.9M
Q1 24
$-56.2M
$61.0M
Gross Margin
BB
BB
ESPR
ESPR
Q4 25
77.5%
Q3 25
74.5%
Q2 25
74.2%
Q1 25
73.5%
Q4 24
78.1%
Q3 24
70.2%
Q2 24
72.9%
Q1 24
Operating Margin
BB
BB
ESPR
ESPR
Q4 25
8.4%
50.6%
Q3 25
8.9%
-11.4%
Q2 25
1.6%
8.6%
Q1 25
-5.6%
-34.0%
Q4 24
13.6%
-6.4%
Q3 24
1.7%
-31.0%
Q2 24
-10.5%
3.5%
Q1 24
50.0%
52.5%
Net Margin
BB
BB
ESPR
ESPR
Q4 25
9.7%
Q3 25
10.3%
-35.9%
Q2 25
1.6%
-15.4%
Q1 25
-5.2%
-62.2%
Q4 24
-7.3%
Q3 24
-15.6%
-57.2%
Q2 24
-33.5%
-83.9%
Q1 24
-55.0%
44.3%
EPS (diluted)
BB
BB
ESPR
ESPR
Q4 25
$0.02
$0.32
Q3 25
$0.02
$-0.16
Q2 25
$0.00
$-0.06
Q1 25
$-0.01
$-0.21
Q4 24
$-0.02
$-0.14
Q3 24
$-0.03
$-0.15
Q2 24
$-0.07
$-0.33
Q1 24
$-0.08
$0.34

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BB
BB
ESPR
ESPR
Cash + ST InvestmentsLiquidity on hand
$304.2M
$167.9M
Total DebtLower is stronger
$196.2M
Stockholders' EquityBook value
$741.1M
$-302.0M
Total Assets
$1.2B
$465.9M
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BB
BB
ESPR
ESPR
Q4 25
$304.2M
$167.9M
Q3 25
$290.5M
$92.4M
Q2 25
$306.6M
$86.1M
Q1 25
$337.8M
$114.6M
Q4 24
$220.0M
$144.8M
Q3 24
$211.0M
$144.7M
Q2 24
$229.0M
$189.3M
Q1 24
$237.1M
$226.6M
Total Debt
BB
BB
ESPR
ESPR
Q4 25
$196.2M
Q3 25
$195.9M
Q2 25
$195.6M
Q1 25
$195.3M
Q4 24
Q3 24
Q2 24
Q1 24
$194.1M
Stockholders' Equity
BB
BB
ESPR
ESPR
Q4 25
$741.1M
$-302.0M
Q3 25
$725.1M
$-451.4M
Q2 25
$725.1M
$-433.5M
Q1 25
$719.9M
$-426.2M
Q4 24
$725.2M
$-388.7M
Q3 24
$732.1M
$-370.2M
Q2 24
$742.6M
$-344.2M
Q1 24
$775.1M
$-294.3M
Total Assets
BB
BB
ESPR
ESPR
Q4 25
$1.2B
$465.9M
Q3 25
$1.2B
$364.0M
Q2 25
$1.2B
$347.1M
Q1 25
$1.3B
$324.0M
Q4 24
$1.3B
$343.8M
Q3 24
$1.3B
$314.1M
Q2 24
$1.3B
$352.3M
Q1 24
$1.4B
$373.1M
Debt / Equity
BB
BB
ESPR
ESPR
Q4 25
0.26×
Q3 25
0.27×
Q2 25
0.27×
Q1 25
0.27×
Q4 24
Q3 24
Q2 24
Q1 24
0.25×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BB
BB
ESPR
ESPR
Operating Cash FlowLast quarter
$18.3M
$45.2M
Free Cash FlowOCF − Capex
$17.4M
FCF MarginFCF / Revenue
12.3%
Capex IntensityCapex / Revenue
0.6%
0.0%
Cash ConversionOCF / Net Profit
1.34×
TTM Free Cash FlowTrailing 4 quarters
$42.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BB
BB
ESPR
ESPR
Q4 25
$18.3M
$45.2M
Q3 25
$3.9M
$-4.3M
Q2 25
$-18.0M
$-31.4M
Q1 25
$41.6M
$-22.6M
Q4 24
$6.0M
$-35.0M
Q3 24
$-16.0M
$-35.3M
Q2 24
$-15.1M
$-7.2M
Q1 24
$-15.5M
$53.8M
Free Cash Flow
BB
BB
ESPR
ESPR
Q4 25
$17.4M
Q3 25
$3.1M
Q2 25
$-18.9M
Q1 25
$41.2M
Q4 24
$5.2M
Q3 24
$-16.5M
$-35.5M
Q2 24
$-16.5M
$-7.3M
Q1 24
$-17.6M
$53.8M
FCF Margin
BB
BB
ESPR
ESPR
Q4 25
12.3%
Q3 25
2.4%
Q2 25
-15.5%
Q1 25
29.1%
Q4 24
3.6%
Q3 24
-13.1%
-68.7%
Q2 24
-13.4%
-9.9%
Q1 24
-17.2%
39.0%
Capex Intensity
BB
BB
ESPR
ESPR
Q4 25
0.6%
0.0%
Q3 25
0.6%
0.0%
Q2 25
0.7%
0.0%
Q1 25
0.3%
0.0%
Q4 24
0.6%
0.0%
Q3 24
0.4%
0.3%
Q2 24
1.1%
0.1%
Q1 24
2.1%
0.1%
Cash Conversion
BB
BB
ESPR
ESPR
Q4 25
1.34×
Q3 25
0.29×
Q2 25
-9.47×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BB
BB

QNX$68.7M48%
Secure Communication$67.0M47%
Licensing$6.1M4%

ESPR
ESPR

Collaboration Revenue$124.7M74%
Products$43.7M26%

Related Comparisons